Showing results (731-740 of 1,242) with videos related to

Sort By:
Pageof 125
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 4, 2015
A preliminary randomized trial of the mechanical insufflator-exsufflator versus breath-stacking technique in patients with amyotrophic lateral sclerosisMuhammad K Rafiq, Michael Bradburn, Alison R Proctor, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 19, 2015
Cognitive behavioural therapy and quality of life in psychologically distressed patients with amyotrophic lateral sclerosis and their caregivers: Results of a prematurely stopped randomized controlled trialAnnerieke C van Groenestijn, Carin D Schröder, Johanna M A Visser-Meily, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 16, 2021
Monocyte CD14 and HLA-DR expression increases with disease duration and severity in amyotrophic lateral sclerosisR B Mcgill, F J Steyn, S T Ngo, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 28, 2020
ALS clinical research learning institutes (ALS-CRLI): empowering people with ALS to be research ambassadorsRichard Bedlack, Allison Pogemiller, Jeremy Shefner, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Arterial blood gas analysis: base excess and carbonate are predictive of noninvasive ventilation adaptation and survival in amyotrophic lateral sclerosisUmberto Manera, Maria Claudia Torrieri, Cristina Moglia, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Use of a new ALS specific respiratory questionnaire: the ARES scoreTerry D Heiman-Patterson, Michael S Sherman, Daohai Yu, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 5, 2021
Development and validation of a machine-learning ALS survival model lacking vital capacity (VC-Free) for use in clinical trials during the COVID-19 pandemicDanielle Beaulieu, James D Berry, Sabrina Paganoni, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 6, 2021
Tailoring patients' enrollment in ALS clinical trials: the effect of disease duration and vital capacity cutoffsMaria Claudia Torrieri, Umberto Manera, Gabriele Mora, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 1, 2022
ALSUntangled #66: antimycobacterial antibioticsEllen S Pierce, Paul Barkhaus, Morgan Beauchamp, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 2, 2022
A geographical study on amyotrophic lateral sclerosis in Rio Grande Do Norte, Brazil, from 2005 to 2018Roberto Teodoro Gurgel De Oliveira, Glauciane Costa Santana, Maria De Jesus Gonçalves, et al.
Pageof 125